Related Experiment Video
Updated: Feb 8, 2026

Modeling Persistent Pseudomonas aeruginosa Infection in Wounded Zebrafish Larvae
Published on: June 13, 2025
Can the quorum sensing inhibitor resveratrol function as an aminoglycoside antibiotic accelerant against Pseudomonas
Jin-Wei Zhou1, Tong-Tong Chen1, Xiao-Juan Tan2
1State Key Laboratory of Marine Resource Utilization in South China Sea, Key Laboratory of Tropical Biological Resources of Ministry Education, Hainan University, Haikou 570228, China; School of Environmental and Biological Engineering, Nanjing University of Science and Technology, Nanjing 210094, China.
Abstract:
Pseudomonas aeruginosa infection is a serious disease in cystic fibrosis patients and is difficult to treat owing to biofilm persistence and emerging multidrug resistance. Considering the essential role of quorum sensing (QS) in P. aeruginosa infections, the enhanced effects between the quorum sensing inhibitor (QSI) resveratrol and several antibiotics against P. aeruginosa PAO1 were investigated. Crystal violet staining assay revealed that biofilms of P. aeruginosa PAO1 grown in the presence of resveratrol were more susceptible to aminoglycoside antibiotics. Scanning electron and fluorescence microscopy showed architectural disruption of the biofilms when treated with resveratrol and aminoglycoside antibiotics. Furthermore, quantitative reverse transcription PCR (qRT-PCR) analysis demonstrated that expression of lasI and rhlI, two genes encoding enzymes that synthesise signal molecules in QS systems, were inhibited in the P. aeruginosa PAO1 biofilms by resveratrol. These results indicate that the QSI resveratrol can significantly enhance the effects of aminoglycoside antibiotics (e.g. tobramycin, gentamicin, amikacin and netilmicin) on P. aeruginosa PAO1 biofilms. These findings suggest that resveratrol is a potential accelerant in the treatment of P. aeruginosa biofilms and can restore or enhance the efficacy of aminoglycoside antibiotics.
Insights
Resveratrol, a quorum sensing inhibitor, enhances aminoglycoside antibiotic effectiveness against Pseudomonas aeruginosa biofilms. This combination therapy shows promise for treating persistent infections in cystic fibrosis patients.
Area of Science:
- Microbiology
- Pharmacology
- Biotechnology
Background:
- Pseudomonas aeruginosa infections are challenging in cystic fibrosis due to biofilms and antibiotic resistance.
- Quorum sensing (QS) plays a critical role in P. aeruginosa virulence and biofilm formation.
Purpose of the Study:
- To investigate the synergistic effects of resveratrol, a QS inhibitor, and aminoglycoside antibiotics against P. aeruginosa biofilms.
- To evaluate resveratrol's potential to restore or enhance antibiotic efficacy in treating P. aeruginosa infections.
Main Methods:
- Crystal violet staining assay to assess biofilm susceptibility.
- Scanning electron and fluorescence microscopy for biofilm structural analysis.
- Quantitative reverse transcription PCR (qRT-PCR) to analyze gene expression related to QS.
Main Results:
- Resveratrol treatment increased P. aeruginosa biofilm susceptibility to aminoglycoside antibiotics.
- Combined resveratrol and aminoglycoside therapy disrupted biofilm architecture.
- Resveratrol inhibited the expression of lasI and rhlI genes involved in P. aeruginosa QS.
Conclusions:
- Resveratrol significantly enhances the efficacy of aminoglycoside antibiotics against P. aeruginosa biofilms.
- Resveratrol acts as a potential therapeutic accelerant, improving treatment outcomes for P. aeruginosa infections.
Related Concept Videos
Estimation of k and VD of Aminoglycosides
Gene Regulation in Microbial Communities: Quorum Sensing
Antibiotic Selection
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
The Sense of Self: Reflected Self-Appraisal and Social Comparison
Accelerators
The effectiveness of calcium chloride can...

